Background: Non-small cell lung cancer (NSCLC) is the leading cause of cancer death
worldwide. Stereotactic body irradiation offers a non-invasive treatment modality for patients …

Introduction. Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung
cancer (NSCLC) is now an accepted and patient friendly treatment, but still controversy …

BACKGROUND AND PURPOSE: The outcome of stage I non-small cell lung cancer
(NSCLC) patients treated with conventional radiotherapy is inferior to that of patients treated …

Purpose: Non–small-cell lung cancer (NSCLC) may not be medically operable even in
patients with surgically resectable disease. For patients who either refuse surgery or are …

BACKGROUND: Stereotactic body radiation therapy (SBRT) represents a substantial
paradigm shift in the treatment of patients with medically inoperable Stage I/II non–small-cell …

Purpose/objective (s) Stereotactic body radiotherapy (SBRT) has become the standard of
care for patients with medically inoperable early-stage non-small cell lung cancer (NSCLC) …

Purpose: To test the effect of stereotactic body radiotherapy (SBRT) in the treatment of
medically inoperable patients with limited-stage non–small-cell lung cancer (NSCLC) in a …

Stereotactic body radiotherapy (SBRT) is a standard treatment for inoperable early-stage
NSCLC, with local control rates comparable to surgical series. Promising results have been …

Patients affected with early stage (IA–IB) non-small cell lung cancer (NSCLC), deemed
medically inoperable, are usually treated by conventional 3D-CRT, with poor results in terms …

Introduction Lung cancer is the most common malignancy worldwide. The standard of care
for early stage lung cancer is surgical resection. Patients with this diagnosis frequently have …